Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmström PU, Choi W, Guo CC, Lotan Y, Kassouf W. Bladder cancer. Lancet. 2016;3(388):2796–810. https://doi.org/10.1016/S0140-6736(16)30512-8.
Falzone L, Salomone S, Libra M. Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. 2018;13(9):1300. https://doi.org/10.3389/fphar.2018.01300.
Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009;61:22–32. https://doi.org/10.1016/s1734-1140(09)70004-0.
Article CAS PubMed Google Scholar
Mruk DD, Xiao X, Lydka M, Li MW, Bilinska B, Cheng CY. Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesis. Semin Cell Dev Biol. 2014;29:43–54. https://doi.org/10.1016/j.semcdb.2013.07.003.
Article CAS PubMed Google Scholar
Guo P, Huang J, Wang L, Jia D, Yang J, Dillon DA, Zurakowski D, Mao H, Moses MA, Auguste DT. ICAM-1 as a molecular target for triple negative breast cancer. Proc Natl Acad Sci USA. 2014;14(111):14710–5. https://doi.org/10.1073/pnas.1408556111.
Usami Y, Ishida K, Sato S, Kishino M, Kiryu M, Ogawa Y, Okura M, Fukuda Y, Toyosawa S. Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/cancer cell adhesion. Int J Cancer. 2013;1(133):568–78. https://doi.org/10.1002/ijc.28066.
Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, Denissenko MF. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis. 2005;26:943–50. https://doi.org/10.1093/carcin/bgi070.
Article CAS PubMed Google Scholar
Tsai ST, Wang PJ, Liou NJ, Lin PS, Chen CH, Chang WC. ICAM1 Is a potential cancer stem cell marker of esophageal squamous cell carcinoma. PLoS ONE. 2015;16(10): e0142834. https://doi.org/10.1371/journal.pone.0142834.
Lim EJ, Kang JH, Kim YJ, Kim S, Lee SJ. ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer. Cell Death Dis. 2022;29(13):417. https://doi.org/10.1038/s41419-022-04862-1.
Gil D, Ciołczyk-Wierzbicka D, Dulińska-Litewka J, Laidler P. Integrin-linked kinase regulates cadherin switch in bladder cancer. Tumour Biol. 2016;37:15185–91. https://doi.org/10.1007/s13277-016-5354-x.
Article CAS PubMed Google Scholar
Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131–42. https://doi.org/10.1038/nrm1835.
Article CAS PubMed Google Scholar
Grünert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol. 2003;4:657–65. https://doi.org/10.1038/nrm1175.
Article CAS PubMed Google Scholar
Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci. 2008;15(121):727–35. https://doi.org/10.1242/jcs.000455.
Yang Z, Zhang X, Gang H, Li X, Li Z, Wang T, Han J, Luo T, Wen F, Wu X. Up-regulation of gastric cancer cell invasion by twist is accompanied by n-cadherin and fibronectin expression. Biochem Biophys Res Commun. 2007;6(358):925–30. https://doi.org/10.1016/j.bbrc.2007.05.023.
Gil D, Ciołczyk-Wierzbicka D, Dulińska-Litewka J, Zwawa K, McCubrey JA, Laidler P. The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT). Adv Enzyme Regul. 2011;51:195–207. https://doi.org/10.1016/j.advenzreg.2010.09.005.
Article CAS PubMed Google Scholar
Howard S, Deroo T, Fujita Y, Itasaki N. A positive role of cadherin in Wnt/β-catenin signalling during epithelial-mesenchymal transition. PLoS ONE. 2011;6: e23899. https://doi.org/10.1371/journal.pone.0023899.
Article CAS PubMed PubMed Central Google Scholar
Najdi R, Holcombe RF, Waterman ML. Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog. 2011;17(10):5. https://doi.org/10.4103/1477-3163.78111.
Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol. 2010;176:2911–20. https://doi.org/10.2353/ajpath.2010.091125.
Article PubMed PubMed Central Google Scholar
Maeda K, Kang SM, Sawada T, Nishiguchi Y, Yashiro M, Ogawa Y, Ohira M, Ishikawa T, Hirakawa-YS CK. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep. 2002;9:511–4.
Gai JQ, Sheng X, Qin JM, Sun K, Zhao W, Ni L. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway. Int J Oncol. 2016;48:338–48. https://doi.org/10.3892/ijo.2015.3250.
Article CAS PubMed Google Scholar
McCubrey JA, Davis NM, Abrams SL, Montalto G, Cervello M, Basecke J, Libra M, Nicoletti F, Cocco L, Martelli AM, Steelman LS. Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy. Adv Biol Regul. 2014;54:176–96. https://doi.org/10.1016/j.jbior.2013.09.013.
Article CAS PubMed Google Scholar
Meares GP, Jope RS. Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis. J Biol Chem. 2007;8(282):16989–7001. https://doi.org/10.1074/jbc.M700610200.
Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol. 2001. https://doi.org/10.1083/jcb.200108077.
Article PubMed PubMed Central Google Scholar
Goc A, Al-Husein B, Katsanevas K, Steinbach A, Lou U, Sabbineni H, DeRemer DL, Somanath PR. Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo. Oncotarget. 2014;15(5):775–87. https://doi.org/10.18632/oncotarget.1770.
Bernardo C, Costa C, Palmeira C, Pinto-Leite R, Oliveira P, Freitas R, Amado F, Santos LL. What we have learned fromurinary bladder cancer models. J Cancer Metastasis Treat. 2016;2:51–8. https://doi.org/10.4103/2394-4722.171279.
Mruk DD, Cheng CY. Enhanced chemiluminescence (ECL) for routine immunoblotting: An inexpensive alternative to commercially available kits. Spermatogenesis. 2011;1:121–2. https://doi.org/10.4161/spmg.1.2.16606.
Article PubMed PubMed Central Google Scholar
Ciołczyk-Wierzbicka D, Gil D, Laidler P. The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines. Curr Med Chem. 2012;19:145–51. https://doi.org/10.2174/092986712803414006.
Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020;108:787–99. https://doi.org/10.1002/JLB.2MR0220-549R.
Article CAS PubMed Google Scholar
Lekka M, Gil D, Dąbroś W, Jaczewska J, Kulik AJ, Lekki J, Stachura Z, Stachura J, Laidler P. Characterization of N-cadherin unbinding properties in non-malignant (HCV29) and malignant (T24) bladder cells. J Mol Recognit. 2011;24:833–42. https://doi.org/10.1002/jmr.1123.
Gil D, Zarzycka M, Dulińska-Litewka J, Ciołczyk-Wierzbicka D, Lekka M, Laidler P. Dihydrotestosterone increases the risk of bladder cancer in men. Hum Cell. 2019;32:379–89. https://doi.org/10.1007/s13577-019-00255-3.
Article CAS PubMed PubMed Central Google Scholar
Lee SH, Wang X, Kim SH, Kim Y, Rodriguez-Puebla ML. Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation. Oncol Lett. 2017;14:2723–34. https://doi.org/10.3892/ol.2017.6551.
Article CAS PubMed PubMed Central Google Scholar
Boonen GJ, van Oirschot BA, van Diepen A, Mackus WJ, Verdonck LF, Rijksen G, Medema RH. Cyclin D3 regulates proliferation and apoptosis of leukemic T cell lines. J Biol Chem. 1999;274:34676–82. https://doi.org/10.1074/jbc.274.49.34676.
Article CAS PubMed Google Scholar
Hui L, Zhang S, Dong X, Tian D, Cui Z, Qiu X. Prognostic significance of twist and N-cadherin expression in NSCLC. PLoS ONE. 2013;3(8): e62171. https://doi.org/10.1371/journal.pone.0062171.
Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem. 2007;13(282):11221–9. https://doi.org/10.1074/jbc.M611871200.
Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, Kahn M. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A. 2007;27(104):5668–73. https://doi.org/10.1073/pnas.0701331104.
留言 (0)